Literature DB >> 27924514

Clinical and sonographic assessment of cervical lymph node metastasis in papillary thyroid carcinoma.

Qi Wu1, Yi-Min Zhang1, Si Sun2, Juan-Juan Li1, Juan Wu3, Xiang Li4, Shan Zhu1, Wen Wei1, Sheng-Rong Sun5.   

Abstract

The purpose of this study was to assess the differences in clinical and sonographic features of papillary thyroid carcinoma (PTC) between cervical lymph node metastatic (CLNM) and nonmetastatic groups. Clinical data of PTC patients (414 patients with 624 malignant nodules) who underwent a preoperative ultrasonography and surgery between June 2010 and March 2015 at Renmin Hospital of Wuhan University were retrospectively analyzed. Clinical factors, preoperative ultrasound features and the final pathological findings were obtained. The differences in the sonographic features of PTC between the CLNM group and the non-CLNM group were analyzed. There were 187 CLNM and 227 non-CLNM patients. The median age at the diagnosis of this cohort was 45.4 years old (ranging from 18 to 77 years). Ultrasonographic parameters that were significantly associated with CLNM [OR=2.569 (1.502, 4.393), P<0.001)] were as follows: the mulifocality of the nodules, size over 2 cm, the presence of microcalcifications, the distance ratio (DR) pattern showing the contact of the nodules with the thyroid capsule, and the extracapsular spread of the nodules. No significant differences in age, gender, thyroid stimulating hormone (TSH) levels and other ultrasonography parameters were found between the CLNM and the non-CLNM groups. Therefore, our results suggest that a larger size, microcalcifications, mulifocality, and the DR pattern showing the contact of the nodules with the thyroid capsule and extracapsular spread are significantly more indicative of CLNM in PTC.

Entities:  

Keywords:  cervical lymph node metastasis; clinical and sonographic assessment; papillary thyroid carcinoma

Mesh:

Year:  2016        PMID: 27924514     DOI: 10.1007/s11596-016-1669-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  22 in total

1.  Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.

Authors:  Kelli D Salter; Peter E Andersen; James I Cohen; Kathyrn G Schuff; Linda Lester; Maisie L Shindo; David Sauer; Neil D Gross
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-07

2.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Steven I Sherman; R Michael Tuttle
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

3.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

4.  Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database.

Authors:  Valerie A Smith; Roy B Sessions; Eric J Lentsch
Journal:  J Surg Oncol       Date:  2012-03-05       Impact factor: 3.454

5.  Association of sonographically detected calcification with thyroid carcinoma.

Authors:  Ning Wang; Yuanhong Xu; Chunlin Ge; Renxuan Guo; Kejian Guo
Journal:  Head Neck       Date:  2006-12       Impact factor: 3.147

6.  Thyroid papillary cancers: microcarcinoma and carcinoma, incidental cancers and non-incidental cancers - are they different diseases?

Authors:  D Barbaro; U Simi; G Meucci; P Lapi; P Orsini; C Pasquini
Journal:  Clin Endocrinol (Oxf)       Date:  2005-11       Impact factor: 3.478

7.  Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer.

Authors:  Sanja Kusacic Kuna; Irena Bracic; Vanja Tesic; Krunoslav Kuna; Gordana Horvatic Herceg; Damir Dodig
Journal:  J Ultrasound Med       Date:  2006-12       Impact factor: 2.153

8.  Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features.

Authors:  Kyung-Eun Kim; Eun-Kyung Kim; Jung Hyun Yoon; Kyung Hwa Han; Hee Jung Moon; Jin Young Kwak
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

9.  Prevalence of thyroid cancer at a medical screening center: pathological features of screen-detected thyroid carcinomas.

Authors:  Yoon Jung Choi; Yong Lai Park; Jang Hyun Koh
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

10.  Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto's thyroiditis.

Authors:  Aleksander Konturek; Marcin Barczyński; Wojciech Nowak; Wojciech Wierzchowski
Journal:  Langenbecks Arch Surg       Date:  2014-01-10       Impact factor: 3.445

View more
  5 in total

1.  Relationship between expression of vascular endothelial growth factor and cervical lymph node metastasis in papillary thyroid cancer: A meta-analysis.

Authors:  Xiao-Qing Huang; Wen-Shan He; Hui-Qiong Zhang; Rui Yang; Tao Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

2.  Predictive value of LN metastasis detected by 18F-FDG PET/CT in patients with papillary thyroid cancer receiving iodine-131 radiotherapy.

Authors:  Chao Li; Jian Zhang; Hui Wang
Journal:  Oncol Lett       Date:  2019-06-19       Impact factor: 2.967

3.  Value of Combining Clinical Factors, Conventional Ultrasound, and Contrast-Enhanced Ultrasound Features in Preoperative Prediction of Central Lymph Node Metastases of Different Sized Papillary Thyroid Carcinomas.

Authors:  Yanfang Wang; Fang Nie; Guojuan Wang; Ting Liu; Tiantian Dong; Yamin Sun
Journal:  Cancer Manag Res       Date:  2021-04-19       Impact factor: 3.989

4.  Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP.

Authors:  Yan Shi; Ying Zou; Jihua Liu; Yuanyuan Wang; Yingbin Chen; Fang Sun; Zhi Yang; Guanghe Cui; Xijun Zhu; Xu Cui; Feifei Liu
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

5.  Radiogenomic Analysis of Papillary Thyroid Carcinoma for Prediction of Cervical Lymph Node Metastasis: A Preliminary Study.

Authors:  Yuyang Tong; Peixuan Sun; Juanjuan Yong; Hongbo Zhang; Yunxia Huang; Yi Guo; Jinhua Yu; Shichong Zhou; Yulong Wang; Yu Wang; Qinghai Ji; Yuanyuan Wang; Cai Chang
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.